Celltrion holdings Nasdaq

South Korea’s leading biosimilar drug developer Celltrion Inc.'s Vegzelma, a cancer drug referencing global biopharma Roche’s Avastin, h...

South Korea’s top four financial holding firms are estimated to have posted their highest-ever profits in 2024, driven by hefty interest incom...

Sono Hospitality Group, South Korea’s top resort operator, has vowed to more actively horn in on the business of T'way Air Co., portending a p...

Korea Investment Holdings Co. said on Thursday it was upgraded by three notches from B to A in the MSCI ESG rating this year.The MSCI ESG rating is ...

SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc. seeks to acquire a domestic health food maker as early as...

K Wave Media Ltd., an umbrella entity of South Korean entertainment companies, is set to go public on the Nasdaq next month in a bid to raise money ...

South Korea's Mirae Asset Global Investments said on Sunday it invested $200 million in Essex Solutions, a US magnet wire manufacturing affiliate un...

South Korea’s two leading drugmakers, Celltrion Inc. and Samsung Bioepis Co., have achieved a significant milestone in the European biosimilar...

South Korea’s steel-to-battery materials conglomerate POSCO Group on Monday unveiled a spate of corporate value-up measures, including a highe...

South Korea's Celltrion Inc. said on Wednesday it received new drug submission (NDS) approval from the Food and Drug Administration (FDA) for Steq...

Celltrion Inc. on Tuesday launched its contract development and manufacturing organization unit Celltrion BioSolutions Co. in its foray into the CDM...

Celltrion Inc. is one step closer to commercializing its four new biosimilars in Europe after a committee of the European Medicines Agency (EMA) rec...

South Korea's government will host an overseas investor relations session to explain the country’s economic conditions and unveil market-boost...

The South Korean won is expected to stage a rebound from its two-year low against the US dollar and hold steady in 2025 after the impeachment of Sou...

South Korea’s biosimilar maker Celltrion Inc. on Friday announced a plan to allot cash and stock dividends simultaneously. The company wi...

South Korea’s GC Biopharma Corp. said on Thursday it acquired the US-based medical-grade source blood plasma company ABO Holding Inc. The...

The National Pension Service (NPS) appears to be stalling on a vote for Doosan Robotics Inc.'s merger with Doosan Bobcat Inc., with major proxy advi...

South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of allergic asthma an...

South Korea’s biosimilar maker Celltrion Inc. on Wednesday announced a plan to retire about a quarter of its treasury stock worth 563 billion ...

South Korea’s leading biosimilar developer Celltrion Inc. will break ground on its first contract development and manufacturing organization (...

The companies founded by South Korean nationals abroad will be recognized as domestic companies if they contribute to the Korean economy, making it ...

Celltrion Inc.'s Remsima, the world’s first biosimilar monoclonal antibody, is on track to exceed 1 trillion won ($713 million) in sales this ...

South Korea's Celltrion Inc. announced on Thursday that it decided to repurchase additional treasury shares worth 100 billion won ($71.6 million).Fr...

South Korea's Celltrion Inc. said on Friday that it completed its acquisition of iQone Healthcare Switzerland, a Swiss pharmaceutical distributor, t...

It can be daunting to do business in a new city in a distant country. But foreign companies seeking to open businesses in South Korea’s capita...

South Korea's Mirae Asset Global Investments said on Tuesday that that its TIGER Nasdaq 100 ETF has become the second US-focused ETF listed in South...

The US stock holdings of South Korean individual investors surpassed $100 billion for the first time, driven by a sustained rally in the US markets ...

Kia Corp., South Korea’s second-largest automaker, said on Thursday it opened a heritage exhibition "From Moments to Movement," showcasing its...

MSCI announced on Wednesday that South Korea's Hyundai Rotem Co. will be added to the Morgan Stanley Capital International (MSCI) Korea Index. ...

Dalton Investments Inc., a US-based activist fund, has secured a 5.02% stake in South Korea’s Kolmar Holdings Co., stoking speculation the wor...